Treatment with a barrier-strengthening moisturizer prevents relapse of hand-eczema. An open, randomized, prospective, parallel group study.

Hand eczema influences the quality of life. Management strategies include the use of moisturizers. In the present study the time to relapse of eczema during treatment with a barrier-strengthening moisturizer (5% urea) was compared with no treatment (no medical or non-medicated preparations) in 53 randomized patients with successfully treated hand eczema. The median time to relapse was 20 days in the moisturizer group compared with 2 days in the no treatment group (p = 0.04). Eczema relapsed in 90% of the patients within 26 weeks. No difference in severity was noted between the groups at relapse. Dermatology Life Quality Index (DLQI) increased significantly in both groups; from 4.7 to 7.1 in the moisturizer group and from 4.1 to 7.8 in the no treatment group (p < 0.01) at the time of relapse. Hence, the application of moisturizers seems to prolong the disease-free interval in patients with controlled hand eczema. Whether the data is applic-able to moisturizers without barrier-strengthening properties remains to be elucidated.

[1]  M. Lodén,et al.  Treatment with a barrier‐strengthening moisturizing cream delays relapse of atopic dermatitis: a prospective and randomized controlled clinical trial , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[2]  J. English,et al.  Consensus statement on the management of chronic hand eczema , 2009, Clinical and experimental dermatology.

[3]  M. Lóden.  Prevention or promotion of dryness and eczema by moisturizers , 2008 .

[4]  T. Agner,et al.  Hand eczema severity and quality of life: a cross‐sectional, multicentre study of hand eczema patients , 2008, Contact dermatitis.

[5]  P. Elias,et al.  Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. , 2008, The Journal of allergy and clinical immunology.

[6]  B. Järvholm,et al.  Hand eczema extent and morphology--association and influence on long-term prognosis. , 2007, The Journal of investigative dermatology.

[7]  M. Lodén,et al.  Changes in skin barrier function following long‐term treatment with moisturizers, a randomized controlled trial , 2007, The British journal of dermatology.

[8]  H. Williams,et al.  What is meant by a "flare" in atopic dermatitis? A systematic review and proposal. , 2006, Archives of dermatology.

[9]  M. Pitt,et al.  A cost‐utility analysis of pimecrolimus vs. topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema , 2006, The British journal of dermatology.

[10]  M. Lóden.  The clinical benefit of moisturizers , 2005, Journal of the European Academy of Dermatology and Venereology : JEADV.

[11]  B. Järvholm,et al.  Fifteen‐year follow‐up of hand eczema: persistence and consequences , 2005, The British journal of dermatology.

[12]  B. Järvholm,et al.  Fifteen-year follow-up of hand eczema: predictive factors. , 2005, The Journal of investigative dermatology.

[13]  P. C. van de Kerkhof,et al.  A randomized comparison of an emollient containing skin‐related lipids with a petrolatum‐based emollient as adjunct in the treatment of chronic hand dermatitis , 2003, Contact dermatitis.

[14]  B Stenberg,et al.  Self‐reported hand eczema: symptom‐based reports do not increase the validity of diagnosis , 2002, The British journal of dermatology.

[15]  R. Graham-Brown.  Systematic Review of Treatments for Atopic Eczema , 2002 .

[16]  J. English,et al.  Advised best practice for the use of emollients in eczema and other dry skin conditions , 2002, The Journal of dermatological treatment.

[17]  E. Bárány,et al.  Skin-identical lipids versus petrolatum in the treatment of tape-stripped and detergent-perturbed human skin. , 2000, Acta dermato-venereologica.

[18]  T. Agner,et al.  Hand eczema in twins: a questionnaire investigation , 2000, The British journal of dermatology.

[19]  T. Stoudemayer,et al.  Objective bioengineering methods to assess the effects of moisturizers on xerotic leg skin of elderly people , 2000 .

[20]  A. Gånemo,et al.  Improved topical treatment of lamellar ichthyosis: a double‐blind study of four different cream formulations , 1999, The British journal of dermatology.

[21]  K. thestrup-pedersen,et al.  Long‐term, intermittent treatment of chronic hand eczema with mometasone furoate , 1999, The British journal of dermatology.

[22]  Andersson,et al.  Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm®) , 1999, The British journal of dermatology.

[23]  A. Finlay,et al.  Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use , 1994, Clinical and experimental dermatology.

[24]  B. Meding,et al.  Occupational hand eczema in an industrial city , 1990, Contact dermatitis.

[25]  B. Meding,et al.  Prevalence of hand eczema in an industrial city , 1987, The British journal of dermatology.

[26]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[27]  H. Rattner.  USE OF UREA IN HAND CREAMS , 1943 .

[28]  V. Preedy,et al.  Dermatology Life Quality Index , 2010 .

[29]  T. Agner,et al.  Effect of long-term use of moisturizer on skin hydration, barrier function and susceptibility to irritants. , 1999, Acta dermato-venereologica.

[30]  M. Lindberg,et al.  The effect of two urea-containing creams on dry, eczematous skin in atopic patients. I. Expert, patient and instrumental evaluation , 1999 .

[31]  K. thestrup-pedersen,et al.  The efficacy of a moisturizer (Locobase) among cleaners and kitchen assistants during everyday exposure to water and detergents. , 1993, Contact dermatitis.

[32]  A. Azon,et al.  Clinical and non-invasive evaluation of 12% ammonium lactate emulsion for the treatment of dry skin in atopic and non-atopic subjects. , 1992, Acta dermato-venereologica.

[33]  G. Swanbeck,et al.  Epidemiology of different types of hand eczema in an industrial city. , 1989, Acta dermato-venereologica.